Kalvehave, Denmark

Kristian Dalsgard

This inventor holds 1 USPTO granted patent. Top assignee: Seed Capital Investment (Sci) B.v.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kristian Dalsgard. Retrieved from https://idiyas.com/inventor/kristian-dalsgard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kristian Dalsgard: Innovator in Cell Culture Technology.

Introduction

Kristian Dalsgard is a notable inventor based in Kalvehave, Denmark. He has made significant contributions to the field of biotechnology, particularly in the area of cultured cells. His innovative work has led to the development of a patent that showcases his expertise and dedication to advancing scientific knowledge.

Latest Patents

Kristian Dalsgard holds a patent for "Cultured cells of quillaja sp." This patent reflects his research and development efforts in utilizing quillaja species for various applications. With 1 patent to his name, Dalsgard continues to push the boundaries of what is possible in cell culture technology.

Career Highlights

Dalsgard is associated with Seed Capital Investment B.V., where he collaborates with other professionals in the field. His work at this company allows him to explore innovative solutions and contribute to the advancement of biotechnology. His career is marked by a commitment to research and development, which has positioned him as a key player in his area of expertise.

Collaborations

One of his notable collaborators is Max Henry. Together, they work on various projects that aim to enhance the understanding and application of cultured cells in different industries.

Conclusion

Kristian Dalsgard is an influential inventor whose work in cultured cells has the potential to impact various sectors. His dedication to innovation and collaboration continues to drive advancements in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…